Review Article

Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges

Table 2

Inflammatory, apoptotic, and oxidative factors in the acute cisplatin nephrotoxicity in rodents.

tissue/
method
analytes measuredD1-D2D3strainRef.
dose

Serum,
urine
ELISA: TNFαns 
ns
ns 
ns
C57BL/6,  [92]  
Urine/MCAIL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12(p70), IL-17, IFN-γ, IP-10, G-CSF, MIP-1α, MCP-1, RANTESnsn.a.10wk, male 
25-30g 
10 mg/kg
Kidney/RT-PCRIL-1β, TNFα, HO-1, IL-18, MCP-1, ICAM-1, TLR4, HMG1n.a.ns
Kidney/ELISATNFα, MCP-1, MIP-2n.a.↑MCP-1, MIP-2

kidney/RPATNF-α, TGF-β, RANTES, MIP-2, IP-10, MCP-1, TCA3, IL-5, IL-9, IL-15, IFN-γTNF-α, TGF-β, RANTES, MIP-2, IP-10, MCP-1, TCA3TNF-α, TGF-β, RANTES, MIP-2, IP-10, MCP-1, TCA3Swiss  
Webster 
[87]
kidney/RT-PCRTNF-α, TGF-β, RANTES, MIP-2, MCP-1,ICAM-1, IL-1ɑ, IL-1βn.a.TNF-α, TGF-β, RANTES, MIP-2, MCP-1, ICAM-1, IL-1β20 mg/kg

Kidney/RT-PCRTNFα, MCP-1, IL-10↑ TNFα, MCP-1↑TNFα, MCP-1, IL-10CD-1, Crl 
Male
[93]
ELISA↑MCP-1↑MCP-125-35g
Plasma/ELISATNFα, MCP-1, IL-10↑MCP-1↑ TNFα, MCP-130 mg/kg

kidney/RT-PCRTNF-α, IL-6, IL-11, LIF, SOCS3, gp130, OSM, CNTF, CT-1, c-fos, HO-1, Bax, Bcl-xl, Bcl-2, Nrf2, MT-1, MT-2, SOD1, SOD2, COX-2, Casp3↑TNF-α, IL-6, IL-11, LIF, SOCS3, OSM, CNTF, c-fos, HO-1, Bax, Bcl-xl,
Bcl-2, Nrf2, MT-1, MT-2
↑TNF-α, IL-6, IL-11, LIF, SOCS3, gp130, OSM, CNTF, c-fos, HO-1, Bax, Bcl-xl, Bcl-2, Nrf2, MT-1, MT-2, COX-2, ↓SOD1
C57BL/6 
Jax  
30 mg/kg
[89, 90]
serum/ELISAIL-6↑IL-6↑IL-6

analytes measuredD3

kidney/RT-PCRTNFα, IL-1β, ICAM-1, MCP-1, TGF-β1, HO-1↑TNF-α, MCP-1, ICAM-1C57BL/6 
20 mg/kg
[94]
kidney/ELISATNFα↑TNFα10-12 wk, 
male

serum/ELISATNF-α↑TNF-αC57BL/6 
male, Jax
kidney/RT-PCRTNF-α, TNFR1, TNFR2, MCP-1,ICAM-1, HO-1↑TNF-α, TNFR1, TNFR2, MCP-1,ICAM-1, HO-120 mg/kg 
N=4-8; ip
[95]

serum/TNF-α, IL-1β, IL-2, IL-6, IL-10, IP-10, MCP-1, RANTES, KC↑TNF-α, IL-1β, IL-6, IL-10, IP-10, ↓IL-2[88]  
kidney/↑TNF-α, IL-6, MCP-1, KC, IP-10C57BL/6 
Jax 
20 mg/kg
urine/MCA↑TNF-α, IL-6, IL-2, RANTES, MCP-1, KC, IP-10
kidney/RT-PCRTNF-α, IL-1β, IL-2, IL-6, IL-18, RANTES, MCP-1, ICAM-1, KC, IP-10, TLR4, iNOS, IFN-ɑ, IFN-β↑TNF-α, IL-1β, IL-6, IL-18, MCP-1, ICAM-1, KC, TLR4, iNOS
kidney/activityp38MAPK activity, p-JNK phosphorylation - Western↑p38MAPK, p-JNK

urine/MCAIL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-17, IFN-γ, IP-10, G-CSF, TNF-ɑ, MIP-1ɑ, MCP-1, RANTES↑TNF-α, IL-6, IL-2, RANTES, IP-10C57BL/6 
Jax
[96]
kidney/RT-PCRHO-1, IL-1β, IL-10, TNF-ɑ, TNFR1, TNFR2↑HO-1, IL-1β, TNF-ɑ, TNFR1, TNFR220 mg/kg
serum/ELISATNF-α↑TNF-α

kidney/MCATNF-α, IL-1β, KC, IFNγ↑TNF-α, IL-1β, KC; ns (24h)C57BL/6J 
40 mg/kg
[69]

kidney/RT-PCRIL-1β, TNFɑ, COX-2, mPGES-1, mPGES-2, cPGES, gp9, p4, NOX-1, NOX-3, SOD1, SOD2, SOD3, Bak, Bax, Bcl-2,↑IL-1β, TNFɑ, COX-2, mPGES-1, ↑gp, p, ↓SOD2, SOD3, ↑Bax, Bak,DBA/1lacJx  
C57BL/6 x  
129/SV  
20 mg/kg
[86] 
ELISA/serumTNF-α↑TNF-α
KidneyPGE2, TNF-α↑ PGE2, TNF-α

D: day; n.a.: not analyzed; MCA: multiplexed cytokine assay; RPA: ribonuclease protection assay; TNFα: tumor necrosis factor alpha; IL: interleukin; IFNγ: interferon gamma; MCP-1: monocyte chemoattractant protein-1; HO-1: heme oxygenase-1; ICAM-1: intracellular adhesion molecule-1; TLR4: toll like receptor 4; TGFβ: tumor growth factor; LIF: leukemia inhibitory factor; CNTF: ciliary neurotrophic factor; gp130: glycoprotein 130; Nrf2: nuclear factor erythroid 2-related factor; OSM: oncostatin M; MT: metallothioneins; SOD: superoxide dismutase; COX: cyclooxygenase; Casp3: caspase 3; iNOS: inducible nitric oxide synthase; KC: keratinocyte-derived chemokine; TNFR1: TNF receptor 1; TNFR2: TNF receptor 2; cPGES: cytosolic prostaglandin E synthase; mPGES: microsomal prostaglandin E synthase; CT-1: cardiotrophin-1; gp and p: two major subunits of NADPH oxidase; MIF: macrophage migration inhibitory factor.